Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE (@bettykimlab) 's Twitter Profile
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE

@bettykimlab

Surgeon Scientist, Professor, Brain Tumor Surgeon, NIH and DOD Funded, #TwinMum, #AIMBE, #ASCI @MDAndersonNews, #Nanomedicine, #immunotherapy. Views are my own

ID: 701854419277643776

calendar_today22-02-2016 19:41:48

1,1K Tweet

1,1K Takipçi

779 Takip Edilen

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

MD Anderson researchers have developed a novel antibody toxin-conjugate that’s not designed to kill the cancer cells directly. Read how this new approach is designed to trigger the body's natural immune response instead: brnw.ch/21wQWWK #EndCancer

Albert Koong, MD PhD (@ackoongmdphd) 's Twitter Profile Photo

Congrats Benjamin Schrank, MD, PhD on this study showing proof of concept that an antibody-toxin conjugate can be used to facilitate immune recognition of tumors. Very promising approach for the development of new cancer therapies! #endcancer MD Anderson Cancer Center nature.com/articles/s4301…

Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE (@bettykimlab) 's Twitter Profile Photo

Thank you ⁦ASCO for featuring our study:⁩ Novel Antibody-Toxin Conjugate Evaluated in Early Study Stay tuned as we work towards bringing this to our patients ⁦MD Anderson Cancer Center⁩ ⁦Benjamin Schrank, MD, PhD⁩ ⁦Yifan Wang, PhD⁩ ascopost.com/news/february-…

OncoDaily (@oncodaily) 's Twitter Profile Photo

Benjamin Schrank, MD, PhD Nature Cancer Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @wenjiang_nano We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing such valuable content. oncodaily.com/blog/benjamin-…

OncoDaily (@oncodaily) 's Twitter Profile Photo

The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate MD Anderson Cancer Center Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to

The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate
<a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/BenjaminSchrank/">Benjamin Schrank, MD, PhD</a> <a href="/BettyKimLab/">Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE</a> 

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to
Kristin Huntoon (@kristinhuntoon) 's Twitter Profile Photo

So grateful for our team and looking forward to what more we can accomplished. Check out our newest manuscript how we target the #STING pathway by #microbubbles and #ultrasound Jacques Lux Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Yifan Wang, PhD U of A College of Medicine Neurosurgery advanced.onlinelibrary.wiley.com/doi/10.1002/ad…

Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE (@bettykimlab) 's Twitter Profile Photo

As we graduate our extraordinary fellows and residents, I am reminded of how little I knew when I thought I knew. From Highschool to Fellowship-Trained Neurosurgeon Scientist: 26 years.Thank you Mom, Dad, Wen, Hannah, teachers/mentors and our patients.

As we graduate our extraordinary fellows and residents, I am reminded of how little I knew when I thought I knew. From Highschool to Fellowship-Trained Neurosurgeon Scientist: 26 years.Thank you Mom, Dad, Wen, Hannah, teachers/mentors and our patients.
Benjamin Schrank, MD, PhD (@benjaminschrank) 's Twitter Profile Photo

🎉 Excited to share in Nature Rev Immunol a Mark Yarmarkovich NYU Langone Health study that dramatically expands the known repertoire of tumour-specific peptides for #tcelltherapies. Huge thanks to Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE and the Preprint Club - Immunology for the cross-instituional collaboration nature.com/articles/s4157…

Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE (@bettykimlab) 's Twitter Profile Photo

Excited to moderate #GRC First Day Gordon Research Conference and our Airport Shuttle bus experienced slight technical issues…2 hours later almost had to hitchhike our way to #Tuscany. Looking forward to what this week will bring. #CancerNanomedicine

Excited to moderate #GRC First Day Gordon Research Conference and our Airport Shuttle bus experienced slight technical issues…2 hours later almost had to hitchhike our way to #Tuscany.  Looking forward to what this week will bring. #CancerNanomedicine
Benjamin Schrank, MD, PhD (@benjaminschrank) 's Twitter Profile Photo

Thrilled to share that I’ve joined MD Anderson Cancer Center as an Assistant Professor & Physician-Scientist in Radiation Oncology--and I’m launching my lab! We’re building a research program at the intersection of genome instability, tumor immunology, and therapeutic development -- and

OncoDaily IO (@oncodailyio) 's Twitter Profile Photo

I’ve Joined MD Anderson Cancer Center as an Assistant Professor and Physician-Scientist in Radiation Oncology - Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Albert Koong, MD PhD oncodaily.com/blog/benjamin-… #RadiationOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #Immunotherapy #ImmuneOnc

I’ve Joined <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> as an Assistant Professor and Physician-Scientist in Radiation Oncology - <a href="/BenjaminSchrank/">Benjamin Schrank, MD, PhD</a>
<a href="/BettyKimLab/">Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE</a> <a href="/ACKoongMDPhD/">Albert Koong, MD PhD</a>

oncodaily.com/blog/benjamin-…

#RadiationOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #Immunotherapy #ImmuneOnc
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research. We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll #EndCancer

Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research.

We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll
#EndCancer